Extended neuroleptic administration modulates NMDA-R subunit immunoexpression in the rat neocortex and diencephalon.

Pharmacol Rep 2016 Oct 6;68(5):990-5. Epub 2016 Jul 6.

Department of Histology, School of Medicine in Katowice, Medical University of Silesia,, Katowice, Poland.

Background: This study aimed to evaluate the effect of extended olanzapine, clozapine and haloperidol administration on NMDA-R subunit immunoexpression in the rat neocortex and diencephalon.

Methods: To explore NR1, NR2A and NR2B subunit protein expression, densytometric analysis of immunohistochemically stained brain slices was performed.

Results: Interestingly, all neuroleptics caused a downregulation of NMDA-R subunit expression in the thalamus but increased the level of NR1 in the hypothalamus. Olanzapine upregulated hypothalamic NR2A expression, while clozapine and haloperidol decreased hypothalamic levels. We observed no significant changes in NR2B immunoreactivity. None of the studied medications had significant influence on NMDA-R subunit expression in the neocortex.

Conclusions: Neuroleptic-induced reduction in the expression of thalamic NMDA-R subunits may play an important role in the regulation of glutamatergic transmission disorders in cortico-striato-thalamo-cortical loop in schizophrenia. A decrease in NMDA signaling in this region after long-term neuroleptic administration may also cautiously explain the incomplete effectiveness of these drugs in the therapy of schizophrenia-related cognitive disturbances.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharep.2016.05.009DOI Listing
October 2016
3 Reads

Publication Analysis

Top Keywords

nmda-r subunit
16
subunit immunoexpression
8
immunoexpression rat
8
rat neocortex
8
clozapine haloperidol
8
subunit expression
8
neuroleptic administration
8
nmda-r
5
expression
5
subunit
5
olanzapine upregulated
4
hypothalamus olanzapine
4
nr1 hypothalamus
4
level nr1
4
upregulated hypothalamic
4
hypothalamic nr2a
4
nmda signaling
4
regulation glutamatergic
4
expression clozapine
4
nr2a expression
4

References

(Supplied by CrossRef)
Design of potent GlyT1 inhibitors; in vitro and in vivo profiles
Bridges et al.
Curr Opin Mol Ther 2008
NMDA receptor subunits: function and pharmacology
Paoletti et al.
CurrOpin Pharmacol 2007
Phenomenology, aetiology and treatment of schizophrenia
Javitt et al.
Novartis Found Symp 2008
NMDA receptor-coupled GlycineB receptors in the pathogenesis and treatment of schizophrenia: a critical review
Millan et al.
Curr Drug Targets 2002

Similar Publications